Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.
about
Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysisRotavirus vaccines in routine useRotavirus vaccines: current status and future considerationsImpact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataBurden of diarrhea, hospitalization and mortality due to cryptosporidial infections in Indian children.Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era.Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.Importance of ICD-10 coding directive change for acute gastroenteritis (unspecified) for rotavirus vaccine impact studies: illustration from a population-based cohort study from Ontario, Canada.Rotavirus vaccines: update on global impact and future prioritiesPopulation-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.Cost effectiveness of infant vaccination for rotavirus in CanadaEffectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control studyEfficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.Molecular epidemiology of group A human rotaviruses in North West region, Cameroon.Methods and challenges for the health impact assessment of vaccination programs in Latin AmericaImpact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance.Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination.Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico.Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Rotarix®: vaccine performance 6 years postlicensure.Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.Impact of rotavirus vaccines on rotavirus disease.Promoting appropriate management of diarrhea: a systematic review of literature for advocacy and action: UNICEF-PHFI series on newborn and child health, India.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.Surface display on lactic acid bacteria without genetic modification: strategies and applications.Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods.Rapid Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and Wales.Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization.Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia.Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children.
P2860
Q26741847-C74C6C04-5AE7-4E3A-95E5-E49D98AFB5A1Q26853690-8BA38EBA-EA73-439F-8BBB-7EA38731E062Q27021385-D05B80D0-894B-4E12-A6E3-9A2529FCB84BQ30000818-F4199788-E897-4E45-BAD0-193CEEF007B7Q33945661-2C80042D-8756-4FB3-A50B-612897389E2EQ34018952-C973D6A1-A62C-449D-A1AD-824655E1978FQ35217987-810408E6-BD39-4AE5-AFC8-BBDEFEC8BB25Q35776813-CEC4D721-CB13-43E7-B4FD-9E4AE30683FBQ35918823-F14A9847-6830-4115-882A-88449657E60AQ36014763-42EA8950-3892-406D-99D7-35B3D7F29195Q36111776-D59452CD-5DB8-40C2-A2BA-1A7AED1D9BFAQ36149373-E81400DC-13F8-4C7E-AF97-D1625FA32930Q36249319-12DE14BC-3E9A-4080-A404-A0F202BF8E1AQ36372451-7A38155D-D71D-481A-95F9-B2C3C94C8890Q36395006-2FEEE314-EB2B-4683-826F-E8B712DECCB6Q36781552-453C7B23-139C-4531-BC94-C39F0839C189Q36978413-8EFAEC6A-8793-48E5-800D-833B0BD52AF8Q37089177-26F8FEC5-1AF4-4CAB-926C-2599536F7867Q37530056-74D03EDF-B7A6-4E83-8FD8-9D95044A6A56Q37607887-8F9BB2F2-7CDC-4B2A-911C-13DC4F232C1BQ37630158-74FC49B7-EB36-45D8-8B6C-3B5445749F88Q37694870-C83532A8-6D16-4485-9A6D-B79492E8AED7Q37694876-4610B78E-2540-4DE5-BB88-B1E3A14F624CQ37944318-7140EFB3-1432-4ED8-9809-819428203EFFQ37956376-CD31593C-29F3-46B7-B0B2-CBF09095EF1DQ37975416-D92D7A18-0443-4C68-9113-D9F63F710EC7Q37981766-961638D4-B6B9-4598-A28F-9D6DFBBE44B6Q38018979-DB7B092E-EADA-4B7B-AB78-AB2B417A470AQ38042034-46480D29-F1BB-4A32-89F9-49B4A73E0F4DQ38046665-9012003D-0B4D-4750-BD96-947044CC2FD1Q38959870-F9750ACC-26AE-422A-BC71-2A8C631FD98BQ40289229-B7912EEA-1B87-4314-B4C8-D269764174BDQ40671330-94FDE77F-F67C-4C08-A44C-1A003DCDDC63Q40722593-93C127F2-52D6-4924-B04C-41FF6E95EB71Q40722602-39E98C0C-9F6A-44C3-9372-07B6ED817B3EQ40722641-CB2C6B01-16EA-4CFE-ABC3-866D91AA1CE8Q40722670-6BD35E8D-EB28-4F4C-9A28-58FF059352E2Q41928438-49DCB0FB-991D-4CD8-AF56-BB1F10557E96Q42232431-B0700038-6D2C-49C3-AF3E-7DE713F161AFQ43223298-4B51D2D2-56B8-432E-B1F1-4F92337C7C0E
P2860
Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@en
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@nl
type
label
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@en
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@nl
prefLabel
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@en
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@nl
P2093
P1476
Impact of rotavirus vaccinatio ...... en < 5 years of age in Mexico.
@en
P2093
Catherine Yen
Manish M Patel
Manjari Quintanar-Solares
Marcelino Esparza-Aguilar
Vesta Richardson
P356
10.1097/INF.0B013E3181FEFB32
P433
P577
2011-01-01T00:00:00Z